Assenagon Asset Management S.A. purchased a new stake in Maximus, Inc. (NYSE:MMS - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 31,975 shares of the health services provider's stock, valued at approximately $1,719,000. Assenagon Asset Management S.A. owned approximately 0.06% of Maximus as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. GAMMA Investing LLC lifted its holdings in Maximus by 33.1% in the 2nd quarter. GAMMA Investing LLC now owns 2,306 shares of the health services provider's stock worth $124,000 after buying an additional 574 shares in the last quarter. Segall Bryant & Hamill LLC acquired a new position in shares of Maximus in the 1st quarter worth $2,019,000. Edgestream Partners L.P. acquired a new stake in shares of Maximus in the first quarter worth $4,060,000. Amundi increased its stake in shares of Maximus by 117.2% in the first quarter. Amundi now owns 5,233 shares of the health services provider's stock worth $335,000 after acquiring an additional 2,824 shares during the last quarter. Finally, California State Teachers Retirement System boosted its holdings in Maximus by 18.8% in the first quarter. California State Teachers Retirement System now owns 63,142 shares of the health services provider's stock worth $4,047,000 after purchasing an additional 9,988 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Weiss Ratings lowered shares of Maximus from a "hold (c)" rating to a "hold (c-)" rating in a research report on Wednesday, May 20th. Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Finally, Zacks Research cut shares of Maximus from a "hold" rating to a "strong sell" rating in a research report on Tuesday. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Maximus currently has an average rating of "Reduce".
Read Our Latest Stock Report on Maximus
Maximus Stock Performance
Shares of MMS stock opened at $55.24 on Friday. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. The stock has a market capitalization of $2.89 billion, a PE ratio of 8.16 and a beta of 0.59. The business's 50 day simple moving average is $58.05 and its 200 day simple moving average is $65.96. Maximus, Inc. has a one year low of $52.73 and a one year high of $100.00.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.21 by $0.01. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a return on equity of 24.91% and a net margin of 7.07%.The company's quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, research analysts forecast that Maximus, Inc. will post 8.01 earnings per share for the current year.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Friday, August 14th. Maximus's dividend payout ratio (DPR) is presently 19.50%.
Maximus Company Profile
(
Free Report)
Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.